291 related articles for article (PubMed ID: 23040422)
41. Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening.
Schöttker B; Raum E; Rothenbacher D; Müller H; Brenner H
Eur J Epidemiol; 2011 Oct; 26(10):779-87. PubMed ID: 21947790
[TBL] [Abstract][Full Text] [Related]
42. Systemic effects of periodontitis treatment in patients with type 2 diabetes: a 12 month, single-centre, investigator-masked, randomised trial.
D'Aiuto F; Gkranias N; Bhowruth D; Khan T; Orlandi M; Suvan J; Masi S; Tsakos G; Hurel S; Hingorani AD; Donos N; Deanfield JE;
Lancet Diabetes Endocrinol; 2018 Dec; 6(12):954-965. PubMed ID: 30472992
[TBL] [Abstract][Full Text] [Related]
43. Use of glucometer and fasting blood glucose as screening tools for diabetes mellitus type 2 and glycated haemoglobin as clinical reference in rural community primary care settings of a middle income country.
Muktabhant B; Sanchaisuriya P; Sarakarn P; Tawityanon W; Trakulwong M; Worawat S; Schelp FP
BMC Public Health; 2012 May; 12():349. PubMed ID: 22583817
[TBL] [Abstract][Full Text] [Related]
44. Impact of early detection and treatment of diabetes on the 6-year prevalence of cardiac autonomic neuropathy in people with screen-detected diabetes: ADDITION-Denmark, a cluster-randomised study.
Charles M; Fleischer J; Witte DR; Ejskjaer N; Borch-Johnsen K; Lauritzen T; Sandbaek A
Diabetologia; 2013 Jan; 56(1):101-8. PubMed ID: 23064291
[TBL] [Abstract][Full Text] [Related]
45. Validity of glycated hemoglobin in screening and diagnosing type 2 diabetes mellitus in Chinese subjects.
Yu Y; Ouyang XJ; Lou QL; Gu LB; Mo YZ; Ko GT; Chow CC; So WY; Ma R; Kong A; Brown N; Nan J; Chan J; Bian RW
Korean J Intern Med; 2012 Mar; 27(1):41-6. PubMed ID: 22403498
[TBL] [Abstract][Full Text] [Related]
46. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials.
Ray KK; Seshasai SR; Wijesuriya S; Sivakumaran R; Nethercott S; Preiss D; Erqou S; Sattar N
Lancet; 2009 May; 373(9677):1765-72. PubMed ID: 19465231
[TBL] [Abstract][Full Text] [Related]
47. Using HbA(1c) to improve efficacy of the american diabetes association fasting plasma glucose criterion in screening for new type 2 diabetes in American Indians: the strong heart study.
Wang W; Lee ET; Fabsitz R; Welty TK; Howard BV
Diabetes Care; 2002 Aug; 25(8):1365-70. PubMed ID: 12145236
[TBL] [Abstract][Full Text] [Related]
48. Population-based stepwise screening for unrecognised Type 2 diabetes is ineffective in general practice despite reliable algorithms.
Christensen JO; Sandbaek A; Lauritzen T; Borch-Johnsen K
Diabetologia; 2004 Sep; 47(9):1566-73. PubMed ID: 15365615
[TBL] [Abstract][Full Text] [Related]
49. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986
[TBL] [Abstract][Full Text] [Related]
50. Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes.
Hayward RA; Reaven PD; Wiitala WL; Bahn GD; Reda DJ; Ge L; McCarren M; Duckworth WC; Emanuele NV;
N Engl J Med; 2015 Jun; 372(23):2197-206. PubMed ID: 26039600
[TBL] [Abstract][Full Text] [Related]
51. Intensive multifactorial intervention improves modelled coronary heart disease risk in screen-detected Type 2 diabetes mellitus: a cluster randomized controlled trial.
Webb DR; Khunti K; Gray LJ; Srinivasan BT; Farooqi A; Wareham N; Griffin SC; Davies MJ;
Diabet Med; 2012 Apr; 29(4):531-40. PubMed ID: 21913966
[TBL] [Abstract][Full Text] [Related]
52. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
Lancet; 1998 Sep; 352(9131):837-53. PubMed ID: 9742976
[TBL] [Abstract][Full Text] [Related]
53. Glycated hemoglobin predicts all-cause, cardiovascular, and cancer mortality in people without a history of diabetes undergoing coronary angiography.
Silbernagel G; Grammer TB; Winkelmann BR; Boehm BO; März W
Diabetes Care; 2011 Jun; 34(6):1355-61. PubMed ID: 21515847
[TBL] [Abstract][Full Text] [Related]
54. Comparing risk profiles of individuals diagnosed with diabetes by OGTT and HbA1c The Danish Inter99 study.
Borg R; Vistisen D; Witte DR; Borch-Johnsen K
Diabet Med; 2010 Aug; 27(8):906-10. PubMed ID: 20653748
[TBL] [Abstract][Full Text] [Related]
55. Using electronic health records to quantify and stratify the severity of type 2 diabetes in primary care in England: rationale and cohort study design.
Zghebi SS; Rutter MK; Ashcroft DM; Salisbury C; Mallen C; Chew-Graham CA; Reeves D; van Marwijk H; Qureshi N; Weng S; Peek N; Planner C; Nowakowska M; Mamas M; Kontopantelis E
BMJ Open; 2018 Jun; 8(6):e020926. PubMed ID: 29961021
[TBL] [Abstract][Full Text] [Related]
56. Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes.
Andersson C; van Gaal L; Caterson ID; Weeke P; James WP; Coutinho W; Finer N; Sharma AM; Maggioni AP; Torp-Pedersen C
Diabetologia; 2012 Sep; 55(9):2348-55. PubMed ID: 22638548
[TBL] [Abstract][Full Text] [Related]
57. Isolated post-challenge hyperglycaemia predicts increased cardiovascular mortality.
Silbernagel G; Sourij H; Grammer TB; Kleber ME; Hartaigh BÓ; Winkelmann BR; Boehm BO; März W
Atherosclerosis; 2012 Nov; 225(1):194-9. PubMed ID: 22995034
[TBL] [Abstract][Full Text] [Related]
58. Glycated haemoglobin and the risk of cardiovascular disease, diabetes and all-cause mortality in the Copenhagen City Heart Study.
Eskesen K; Jensen MT; Galatius S; Vestergaard H; Hildebrandt P; Marott JL; Jensen JS
J Intern Med; 2013 Jan; 273(1):94-101. PubMed ID: 23009556
[TBL] [Abstract][Full Text] [Related]
59. Screening for type 2 diabetes: do screen-detected cases fare better?
Feldman AL; Griffin SJ; Fhärm E; Norberg M; Wennberg P; Weinehall L; Rolandsson O
Diabetologia; 2017 Nov; 60(11):2200-2209. PubMed ID: 28831538
[TBL] [Abstract][Full Text] [Related]
60. Impaired glucose metabolism among those with and without diagnosed diabetes and mortality: a cohort study using Health Survey for England data.
Gordon-Dseagu VL; Mindell JS; Steptoe A; Moody A; Wardle J; Demakakos P; Shelton NJ
PLoS One; 2015; 10(3):e0119882. PubMed ID: 25785731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
